The National Cancer Institute noted a national study of Medicare beneficiaries' prescriptions for opioids and questioned whether cancer patients were receiving the opioids they needed to control pain.
The National Cancer Institute noted a national study of Medicare beneficiaries' prescriptions for opioids and questioned whether cancer patients were receiving the opioids they needed to control pain.
